October 2016: An RCT evaluating simvistatin for treatment of Smith-Lemli-Optiz Syndrome.

October 2016: An RCT evaluating simvistatin for treatment of Smith-Lemli-Optiz Syndrome.

October 2016:&nbsp;An RCT evaluating simvistatin for treatment of Smith-Lemli-Optiz Syndrome.

Genetics in Medicine: October 2016

Genetics in Medicine (GIM) is the official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.

Share Genetics in Medicine: October 2016

Sign up to save your podcasts

Genetics in Medicine: October 2016

Genetics in Medicine: October 2016